CTRI/2022/08/044929尚未招募4 期
An Open-label PILOT Clinical Study to evaluate the safety and gastrointestinal tolerance (Product Compliance) of Groviva Advance in Hospitalized children requiring isocaloric formula for enteral tube feeding
Dr Chetan Mehndiratta Modi Mundi Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •1.Ready to Sign informed consent form or informed consent form signed by
- •legally acceptable representatives.
- •2.Aged 2-18 years
- •3.Gender: Male & Female.
- •4.Hospitalized patients requiring isocaloric formula for enteral feeding.
- •5.Can tolerate enteral tube feeding.
- •6.Estimated duration of Hospital stays equal to or greater than 2 days.
排除标准
- •1.Receiving tube feeding prior to hospitalization.
- •2.Patients more than 18 years of age.
- •3.Patients having allergy to constituents of Groviva Advance.
- •4.Any evidence of organ dysfunction or any clinically significant deviation from the normal, in
- •physical or clinical determinations.
- •5.History of renal, hepatic, cardiovascular, respiratory, skin, hematological, endocrine, neurological,
- •or gastrointestinal diseases.
研究者
相似试验
尚未招募
2 期
Evaluation the efficacy of Siddha medicine (Soothaga Mezhugu) for the treatment of Polycystic Ovarian Syndrome.CTRI/2024/06/068998il
尚未招募
2 期
Clinical Trial for Diabetic Foot Ulcer through Siddha medicinesCTRI/2023/10/058661ational Institute of Siddha
尚未招募
2 期
To access the cost and effectiveness of Aripiprazole treatment in schizophrenia patients using gene based markersCTRI/2023/09/057176AJIITH XAVIER F
已完成
不适用
The study to assess the safety of Serioss® (SF Scaffold) in patients.CTRI/2021/01/030589Serigen Mediproducts Pvt Ltd
已完成
2 期
A clinical study on THOKKANAM (PIDITHAL MURAI) ââ?¬â?? An external therapy using NATHAI CHOORI ENNAI (EXTERNAL) in the management of THANDAGA VATHAM (LUMBAR SPONDYLOSIS)CTRI/2021/02/031340Government siddha medical College and hospital40